A study by Zhu et al. found that rs7573065 in SLC11A1 caused an increased risk and a reduced overall survival rate of prostate cancer, suggesting SLC11A1 as a candidate risk factor and prognostic biomarker for prostate cancer [39]. Here, SLC11A1 is linked to prostate carcinoma.